-
December 21, 2021 by
Neal Goswami & Ed Neuert
Jason Sanders, M.D., M.B.A., has been appointed to fill three critical executive leadership roles – senior associate dean for clinical affairs at the UVM Larner College of Medicine, president and CEO of the UVM Health Network Medical Group, and Network executive vice president for clinical affairs. He will begin his work for the College and the Network in February 2022.
-
December 16, 2022 by
Cardiovascular Research Institute of Vermont
Funding Announcement: A unique funding opportunity for Early Career investigators who are developing new skills and/or who are seeking a novel research experience aimed at developing a career in cardiovascular research.
-
December 15, 2021 by
Ed Neuert
Mitchell Wolfe, M.D., M.P.H., chief medical officer for the Centers for Disease Control and Prevention (CDC) and a Class of 1995 Larner alum, returned to campus for a personal visit on December 13 for the first time since receiving his medical degree here 26 years ago.
-
December 14, 2021 by
Jennifer Nachbur
(DECEMBER 14, 2021) A Burlington Free Press article about Chittenden County, Vt. building projects mentioned the Firestone Medical Research Building currently under construction on the UVM campus.
-
December 13, 2021 by
Jennifer Nachbur
(DECEMBER 13, 2021) A visit to UVM's Larner College of Medicine by Class of 1995 alum Mitchell Wolfe, M.D., M.P.H., chief medical officer for the Centers for Disease Control and Prevention (CDC), was covered widely by regional media.
-
November 30, 2021 by
Nicole Twohig
VCBH COBRE Project Leader Sherrie Khadanga, MD had the results of her randomized clinical trial (RCT) examining high-intensity interval training (HIIT) for women in cardiac rehabilitation published online in JAMA Cardiology on November 24, 2021.
-
November 24, 2021 by
Jennifer Nachbur
(NOVEMBER 24, 2021) Jan Carney, M.D., M.P.H., associate dean for public health and health policy, and Mark Levine, M.D., Vermont Commissioner of Health and professor of medicine, are both quoted in an article in The Atlantic, titled "America’s Pandemic Star Loses Some Luster," regarding the surge in COVID-19 cases in Vermont.
-
November 23, 2021 by
Jennifer Nachbur
New research from U.S. Breast Cancer Surveillance Consortium (BCSC) members, including several University of Vermont researchers, found that from March to September 2020, breast biopsies and detected cancers at U.S. BCSC facilities dropped sharply, compared with the same span a year earlier.
-
November 18, 2021 by
User Not Found
-
November 17, 2021 by
Jennifer Nachbur
Researchers at the University of Vermont recently received a $5.5 million, five-year grant to participate in the Phase II portion of the HEALthy Brain and Child Development (HBCD) Study, an initiative focused on gathering data on brain development from birth through early childhood.
-
November 4, 2021 by
User Not Found
-
November 4, 2021 by
User Not Found
-
November 3, 2021 by
Christina Davenport
With $3 million in support from a longtime major supporter of the University of Vermont Cancer Center, Randall F. Holcombe, M.D., M.B.A., was invested as the inaugural J. Walter Juckett Chair in Cancer Research in the Larner College of Medicine on November 3.
-
November 3, 2021 by
Ed Neuert
The Larner College of Medicine at the University of Vermont has been awarded continued accreditation for a full eight-year term by the Liaison Committee on Medical Education (LCME), the accrediting body for all M.D. degree programs in the U.S. and Canada.
-
October 29, 2021 by
Jennifer Nachbur
The University of Vermont’s Larner College of Medicine held a successful Dean's Excellence in Research Celebration October 25-27, shining a light on the hard work and achievements of students, faculty, staff, and alumni.
-
October 29, 2021 by
Vermont Center for Cardiovascular and Brain Health
Congratulations to Dr. Emmett Whitaker for being awarded a 2021 Foundation for Anesthesia Education and Research Mentored Research Training Grant (MRTG).
-
October 26, 2021 by
Katherine Strotmeyer
Linked to occupational asbestos exposure, malignant mesothelioma (MM) is an aggressive cancer arising primarily from the outer lining of the lungs with a dismal five-year survival rate of only five to 10 percent. Since 2004, only two therapies have been approved for the treatment of MM, which affects about 3,000 people a year in the United States. Now a promising new therapy for mesothelioma and metastatic cancer, arising from laboratory investigations at the University of Vermont, is about to enter a Phase I clinical trial.
-
October 22, 2021 by
Michelle Bookless
Tis the season for coats – white coats that is!
On Friday, October 15, the University of Vermont Neuroscience Graduate Program (NGP) hosted its annual White Coat Ceremony in the Livak Ballroom of the UVM Davis Center.
While often associated with medical education, the White Coat Ceremony for new graduate degree students has its own history, dating back to 1989, according to Haley Olszewski, NGP program administrator. The ceremony is a rite of passage for many graduate students, she says, both “marking the transition of graduate students, particularly in the sciences, from the early, largely course-based phase of their education to the more research intense phase of their training.” The event also serves to “emphasize the relationship between the student and their mentor,” she adds.
-
October 19, 2021 by
Jennifer Nachbur
Lewis First, M.D., M.S., professor and chair of pediatrics, has announced the appointment of Rachel Garfield, M.H.S., Ph.D., as the next executive director of the Vermont Child Health Improvement Program (VCHIP) and an associate professor pediatrics at the University of Vermont Larner College of Medicine.
-
October 18, 2021 by
Susan Davidson
Two members of the Larner College of Medicine community--Nick Lemon, information systems technical support staff member, and Katherine Strotmeyer, communications and community outreach director for the University of Vermont Cancer Center--were among the UVM stafff members who received a 2021 Our Common Ground award.